Exelixis Traders Brace For Upcoming FDA Decision Proactive Investors USA & Canada ... Drugs Advisory Committee meeting (originally scheduled to take place between November 8th and 9th), the market will actually be heading into a FDA decision with nothing more than the related phase III clinical trial data that Exelixis released ...
No comments:
Post a Comment